Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Pfizer Consumer Licenses Antares Delivery Tech | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Pfizer Consumer Licenses Antares Delivery Tech

Pfizer to cover development, commercialization, pay milestones, royalties

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Pfizer’s Consumer Healthcare Business Unit has licensed a drug delivery technology from Antares Pharma to develop an undisclosed product on an exclusive basis for North America. Pfizer will assume full cost and responsibility for all clinical development, manufacturing, and commercialization of the product in the licensed territory, which also includes certain non-exclusive territories outside of North America. Antares will receive undisclosed upfront payments, development milestones and sales based milestones, as well as royalties on net sales for three years after U.S. launch.

“We are very pleased to enter this collaboration with Pfizer Consumer Healthcare for an important product opportunity targeting a growing therapeutic area which utilizes one of our technology platforms,” said Paul K. Wotton, Ph.D., Antares’ president and chief executive officer. “We continue to significantly diversify our existing and future product portfolio through both internal product development programs and Pharma partnerships.”

Antares has partnerships with several other pharma companies, including Teva, Ferring and Watson.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics